Hospital Mortality and Morbidity in Diabetic Patients with COVID-19: A Retrospective Analysis from the UAE

Yehia S Mohamed1,2, Mamoun Mukhtar3, Akrem Elmalti4

  • 1Department of Pathological Sciences, College of Medicine, Ajman University, Ajman P.O. Box 346, United Arab Emirates.

Insights

Diabetic patients hospitalized with COVID-19 experienced worse outcomes, including higher mortality and longer hospital stays. Effective diabetes management is crucial for improving COVID-19 patient prognosis.

Area of Science:

  • Infectious Diseases
  • Endocrinology
  • Public Health

Background:

  • Conflicting evidence exists on COVID-19 outcomes for hospitalized diabetic patients.
  • Diabetes Mellitus (DM) is a significant comorbidity impacting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection course.
  • Understanding these disparities is crucial for targeted interventions during pandemics.

Purpose of the Study:

  • To evaluate in-hospital mortality and morbidity in diabetic versus nondiabetic patients hospitalized with COVID-19.
  • To compare clinical outcomes including length of stay, ICU admission, and mechanical ventilation needs.
  • To provide data from the Northern UAE Emirates to inform clinical practice.

Main Methods:

  • Retrospective analysis of clinical data from COVID-19 patients admitted between March 2020 and April 2021.
  • Inclusion criteria: patients with or without Diabetes Mellitus (DM).
  • Endpoints assessed: all-cause in-hospital mortality, hospitalization duration, ICU admission, and mechanical ventilation.

Main Results:

  • 335 out of 427 (78.5%) patients had DM.
  • Diabetic patients had significantly longer hospital stays (OR=2.35) and higher ICU admission rates (OR=4.50).
  • In-hospital mortality was significantly higher in diabetic patients (OR=2.26) compared to nondiabetics; mechanical ventilation rates were similar.

Conclusions:

  • Diabetes Mellitus is associated with a more severe COVID-19 course.
  • Diabetic COVID-19 patients face increased mortality, longer hospitalizations, and higher ICU admission rates.
  • Strict DM control is vital for mitigating adverse outcomes in COVID-19 patients.
Abstract